https://sanofi.com

Advancing Healthcare with Sanofisanofi, sanofi pharmaceuticals, sanofi companyExplore Sanofi's global impact through our science, healthcare R&D, and partnerships. Committed to advancing global health with innovative solutions.Advancing Healthcare with SanofiOur CompanyOur CompanyOur StrategyGovernanceGovernanceBoard of DirectorsExecutive CommitteeSpecialist CommitteesOur LegacySocial ImpactSocial ImpactAccess to HealthcareInnovation for Vulnerable CommunitiesEnvironmental Sustainability and ResilienceDiversity, Equity, and Inclusion In and Beyond the WorkplaceCode of Conduct and Responsible BusinessOur ScienceOur ScienceOur PipelineR&D Focus AreasR&D Focus AreasImmunology R&DNeurology R&DOncology R&DRare Blood Disorders R&DRare Diseases R&DVaccines R&DArtificial Intelligence in R&D Technology Platforms Clinical Trials & ResultsClinical Trials & ResultsFind a Clinical TrialClinical Study ResultsInvestigator Sponsored StudiesDiversity in Clinical TrialsScientific CollaborationScientific CollaborationScientific Collaboration in North AmericaScientific Collaboration in EuropeScientific Collaboration in ChinaDigitalManufacturing and SupplyYour HealthYour HealthVaccinesVaccinesInfluenzaMeningococcal MeningitisPertussisRespiratory Syncytial Virus (RSV)ProductionWhy vaccines matterMedicinesMedicinesImmunologyNeurologyOncologyRare Blood DisordersRare DiseasesCardiovascular DiseasesDiabetesConsumer HealthcareConsumer HealthcareSustainability at Sanofi Consumer HealthcareAllergyCough, Cold & FluDigestive WellnessPain CarePhysical & Mental WellnessPatient Community EngagementHealthcare Professionals SupportHealthcare Professionals SupportManaged Access Programs (MAPs)Pre-Registration Import LicensesPost Trial Access (PTA)PartneringPartneringPartnering Focus AreasPartnering Focus AreasChinaDigitalGeneral MedicinesImmunologyNeuroscienceOncologyOut-LicensingRare DiseaseTechnology PlatformsVaccinesMeet the Partnering TeamContact Business Development TeamMediaMediaStoriesPress ReleasesContactsInvestorsInvestorsNewsResults and PresentationsResults and PresentationsResultsPresentationsConferencesEnvironment, Social, GovernanceEnvironment, Social, GovernanceOur Latest ESG newsESG quarterly updatePrivate ShareholdersShares and ADRsShares and ADRsSanofi stock chartDividendADRsShares, Structure & VoteAnalyst CoverageVara consensusShare repurchasesBondsContactsCareersCareersStart Something IncredibleExplore Life as a SanofianUnlock Your Total Rewards and BenefitsFind Your Next RoleGlobal Terms and ConditionsParis 2024Paris 2024Meet Team SanofiFollow the Paris 2024 Olympic and Paralympic Torches RelaysGlobalRedefining R&DHow Immunoscience is Driving the Pipeline of the FutureDiscover moreOur Latest StoriesRead our latest articlesSocial ImpactSeptember 25, 2024Foundation S at UNGA: Addressing Climate and Health ResilienceRead the articleOur ScienceSeptember 23, 2024Partner Spotlight: AQEMIA and Sanofi Harness Generative AI and Deep Physics to Power R&DRead the articleOur ScienceSeptember 17, 2024Every Breath Matters: Addressing Unmet Needs in Respiratory Care Read the articleThird quarter 2024 resultsThird quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.  Friday October 25, 2024 14:00 - 15:30 CET (8:00am – 9:30am EST) Discover moreRegister hereUnited by PurposeEach of us plays a unique role in bringing our purpose to life. Igniting the Potential in EveryoneWe’re proud to be premium partner of Paris 2024. Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends. Read more about the partnershipAbout UsWho We AreWe are an innovative global healthcare company. Read moreOur Science We turn the impossible into possible. Read moreYour HealthWe chase the miracles of science to improve people’s lives.  Read moreOur CommitmentWe have reimagined a bold sustainable approach. Read moreOur Pipeline5Therapeutic areas 78Compounds in clinical development 29Clinical trials in phase 3 Explore our pipelinePursue Progress. Discover Extraordinary. Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better. Explore Career Opportunities Our Latest Press ReleasesSeptember 27, 2024Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPDRead the Press ReleaseSeptember 27, 2024Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPDRead the Press ReleaseSeptember 26, 2024Press Release: Availability of the Q3 2024 Aide mémoireRead the Press ReleaseSeptember 25, 2024Media Update: EADV: New data reinforce Sanofi’s innovative approach and leadership across immune-mediated skin diseasesRead the Press ReleaseSee all press releasesFollow usBack to topStoriesContactLegal noticePrivacy & data protectionOur publicationsCookies PolicySitemapDirectoryAccessibility: partial complianceCode of Conduct© Sanofi 2004-2024 - All rights reservedenen1730348821https://sanofi.com

Editeu el vostre lloc?

Què estàs fent?